<VariationArchive RecordType="classified" VariationID="242862" VariationName="Single allele" VariationType="Duplication" Accession="VCV000242862" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2016-07-09" MostRecentSubmission="2016-07-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="243966" VariationID="242862">
      <GeneList>
        <Gene Symbol="MECP2" FullName="methyl-CpG binding protein 2" GeneID="4204" HGNC_ID="HGNC:6990" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154021573" stop="154097717" display_start="154021573" display_stop="154097717" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153287263" stop="153363187" display_start="153287263" display_stop="153363187" Strand="-" />
          </Location>
          <OMIM>300005</OMIM>
          <Haploinsufficiency last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-02-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MECP2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>Single allele</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq27.1-28</CytogeneticLocation>
        <SequenceLocation Assembly="NCBI36" AssemblyAccessionVersion="GCF_000001405.12" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.9" innerStart="139330000" innerStop="154580000" display_start="139330000" display_stop="154580000" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="Single allele AND Syndromic X-linked intellectual disability Lubs type" Accession="RCV000234878" Version="1">
        <ClassifiedConditionList TraitSetID="3220">
          <ClassifiedCondition DB="MedGen" ID="C1846058">Syndromic X-linked intellectual disability Lubs type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-03-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-03-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-07-09" MostRecentSubmission="2016-07-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3220" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2613" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MENTAL RETARDATION, X-LINKED, WITH RECURRENT RESPIRATORY INFECTIONS</ElementValue>
                <XRef Type="MIM" ID="300260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lubs X-linked mental retardation syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUBS TYPE</ElementValue>
                <XRef Type="MIM" ID="300260" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XLMR syndrome, Lubs type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation, X-linked, Lubs type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MECP2 duplication syndrome</ElementValue>
                <XRef ID="MECP2+duplication+syndrome/4540" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Syndromic X-linked intellectual disability Lubs type</ElementValue>
                <XRef ID="MONDO:0010283" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRXSL</ElementValue>
                <XRef Type="MIM" ID="300260" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">MECP2 duplication syndrome is a severe neurodevelopmental disorder characterized by early-onset hypotonia, feeding difficulty, gastrointestinal manifestations including gastroesophageal reflux and constipation, delayed psychomotor development leading to severe intellectual disability, poor speech development, progressive spasticity, recurrent respiratory infections (in ~75% of affected individuals), and seizures (in ~50%). MECP2 duplication syndrome is 100% penetrant in males. Occasionally females have been described with a MECP2 duplication and a range of findings from mild intellectual disability to a phenotype similar to that seen in males. In addition to the core features, autistic behaviors, nonspecific neuroradiologic findings on brain MRI, mottled skin, and urogenital anomalies have been observed in several affected boys.</Attribute>
                <XRef ID="NBK1284" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9781" />
                <XRef ID="9781" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301461</ID>
                <ID Source="BookShelf">NBK1284</ID>
              </Citation>
              <XRef ID="1762" DB="Orphanet" />
              <XRef ID="C1846058" DB="MedGen" />
              <XRef ID="MONDO:0010283" DB="MONDO" />
              <XRef Type="MIM" ID="300260" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="556502" SubmissionDate="2015-11-15" DateLastUpdated="2016-07-09" DateCreated="2016-07-09">
        <ClinVarSubmissionID localKey="Patient 2_Xq28 dup_15.25Mb|OMIM:300260" submittedAssembly="NCBI36" />
        <ClinVarAccession Accession="SCV000291990" DateUpdated="2016-07-09" DateCreated="2016-07-09" Type="SCV" Version="1" SubmitterName="Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine" OrgID="505572" OrganizationCategory="laboratory" OrgAbbreviation="BHCMG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-03-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Nageshappa et al. (Mol Psychiatry. 2016)</Attribute>
          <Citation>
            <ID Source="PubMed">26347316</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
              <FamilyData NumFamiliesWithSegregationObserved="1" NumFamiliesWithVariant="1">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
            </Sample>
            <Method>
              <TypePlatform>microarray</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MECP2" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <Location>
            <SequenceLocation Assembly="NCBI36" Chr="X" innerStart="139330000" innerStop="154580000" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">2</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="ReferenceCopyNumber">1</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="300260" Type="MIM" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">26347316</ID>
        </Citation>
        <StudyDescription>Induced pluripotent stem cells (iPSCs) from patients with the MECP2 duplication syndrome (MECP2dup), carrying different duplication sizes, were generated to study the impact of increased MeCP2 dosage in human neurons.</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>Nageshappa_MolPsych_2015_MECP2</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="556502" TraitType="Disease" MappingType="XRef" MappingValue="300260" MappingRef="OMIM">
        <MedGen CUI="C1846058" Name="Syndromic X-linked intellectual disability Lubs type" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

